Study of Intramuscular Ropivacaine Injections for Treatment of Pediatric Headache

• Status: Completed
• Trial end date: 2016-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Objective: To determine if lower paracervical intramuscular ropivacaine injection is an effective treatment for pediatric headache in an emergency department setting.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Children's Hospital of Pittsburgh; Robert Hickey
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Chief complaint of headache

• Age 7-17 years

Exclusion Criteria:

• Presence of fever

• meningismus

• headache that wakes the child at night

• known organic brain disease, mass, or tumor

• history of stroke

• history of allergy to ropivacaine or other aminoacyl local anesthetics

• history of liver disease

• history of impaired cardiac function

• abnormal neurologic signs

• a focal neurologic abnormality on exam that is not a known component of the child's headache syndrome

• cognitive inability to communicate the intensity of pain.

• history of shunt or other intracranial hardware